BioAge Labs, Inc. (BIOA)
5.965
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
5.965
0.00 (0.00%)
After-Hours: 18:52
BioAge Labs Total Return Price : 5.965 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 5.96 |
| November 02, 2026 | 5.80 |
| October 30, 2026 | 5.87 |
| October 29, 2026 | 5.94 |
| October 28, 2026 | 5.94 |
| October 27, 2026 | 5.47 |
| October 26, 2026 | 4.99 |
| October 23, 2026 | 5.10 |
| October 22, 2026 | 5.53 |
| October 21, 2026 | 5.51 |
| October 20, 2026 | 5.56 |
| October 19, 2026 | 4.99 |
| October 16, 2026 | 4.84 |
| October 15, 2026 | 5.35 |
| October 14, 2026 | 5.42 |
| October 13, 2026 | 5.57 |
| October 12, 2026 | 5.94 |
| October 09, 2026 | 6.34 |
| October 08, 2026 | 6.21 |
| October 07, 2026 | 6.26 |
| October 06, 2026 | 6.29 |
| October 05, 2026 | 6.36 |
| October 02, 2026 | 6.61 |
| October 01, 2026 | 6.81 |
| September 30, 2026 | 7.09 |
| Date | Value |
|---|---|
| September 29, 2026 | 7.14 |
| September 28, 2026 | 7.18 |
| September 25, 2026 | 7.05 |
| September 24, 2026 | 7.21 |
| September 23, 2026 | 7.89 |
| September 22, 2026 | 8.46 |
| September 21, 2026 | 8.09 |
| September 18, 2026 | 8.06 |
| September 17, 2026 | 8.09 |
| September 16, 2026 | 7.75 |
| September 15, 2026 | 8.18 |
| September 14, 2026 | 8.48 |
| September 11, 2026 | 8.49 |
| September 10, 2026 | 8.65 |
| September 09, 2026 | 9.17 |
| September 08, 2026 | 9.395 |
| September 04, 2026 | 9.59 |
| September 03, 2026 | 9.50 |
| September 02, 2026 | 9.73 |
| September 01, 2026 | 9.52 |
| August 31, 2026 | 9.50 |
| August 28, 2026 | 9.65 |
| August 27, 2026 | 10.08 |
| August 26, 2026 | 9.84 |
| August 25, 2026 | 10.11 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Neumora Therapeutics, Inc. | 0.5661 |
| Alumis, Inc. | 6.555 |
| ANI Pharmaceuticals, Inc. | 71.68 |
| Corcept Therapeutics, Inc. | 79.20 |
| Veru, Inc. | 2.20 |